chr6-28995786-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001382360.1(ZNF311):āc.1216A>Gā(p.Ile406Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,613,828 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001382360.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF311 | NM_001382360.1 | c.1216A>G | p.Ile406Val | missense_variant | 7/7 | ENST00000377179.4 | NP_001369289.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF311 | ENST00000377179.4 | c.1216A>G | p.Ile406Val | missense_variant | 7/7 | 5 | NM_001382360.1 | ENSP00000366384.3 | ||
ZNF311 | ENST00000483450.1 | n.2026A>G | non_coding_transcript_exon_variant | 6/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152074Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000563 AC: 14AN: 248490Hom.: 0 AF XY: 0.0000667 AC XY: 9AN XY: 134916
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461754Hom.: 0 Cov.: 35 AF XY: 0.0000165 AC XY: 12AN XY: 727184
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152074Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74282
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2023 | The c.1216A>G (p.I406V) alteration is located in exon 7 (coding exon 6) of the ZNF311 gene. This alteration results from a A to G substitution at nucleotide position 1216, causing the isoleucine (I) at amino acid position 406 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at